Pharmagreen Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May '26 May 1, 2026	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Market Capitalization	1	3	0	4	10	8
Market Cap Growth	40.31%	594.36%	-90.92%	-57.81%	36.76%	-94.87%
Enterprise Value	2	3	1	5	11	8
Last Close Price	0.00	0.00	0.00	0.01	0.03	0.08
PS Ratio	496.29	817.39	133.90	-	-	-
PB Ratio	-0.62	-0.89	-0.18	-2.43	-6.19	-2.61
EV/Sales Ratio	-	907.68	249.79	-	-	-
Debt / Equity Ratio	-0.15	-0.11	-0.17	-0.19	-0.16	-0.24
Net Debt / Equity Ratio	-0.15	-0.11	-0.17	-0.18	-0.14	-0.24
Net Debt / FCF Ratio	-10.66	-12.67	-5.03	-0.77	-1.19	-1.16
Asset Turnover	0.03	0.03	0.02	-	-	-
Inventory Turnover	0.20	0.20	-	-	-	-
Quick Ratio	0.00	0	0.00	0.00	0.01	0.00
Current Ratio	0.04	0.00	0.02	0.11	0.18	0.08
Return on Assets (ROA)	-139.13%	-141.50%	-179.26%	-229.74%	-147.17%	-67.73%
Return on Capital Employed (ROCE)	10.10%	8.20%	22.70%	62.80%	45.50%	16.70%
Earnings Yield	-15.19%	-36.04%	-141.69%	-19.80%	-43.24%	-31.81%
FCF Yield	-	-1.01%	-18.39%	-9.64%	-1.97%	-7.93%
Buyback Yield / Dilution	-28.47%	-41.33%	-15.55%	-37.46%	-257.86%	-10.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.